CYNTHIA ROGER: Open Payments
NPI 1548469141 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,280 in 170 payments from 27 companies in 2025. Trend: 2023 $2,905 · 2024 $3,806 · 2025 $3,280
Food & beverage: $3,258Education: $22
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 33 | $602 |
| AstraZeneca Pharmaceuticals LP | 25 | $513 |
| Insmed, Inc. | 21 | $456 |
| Regeneron Healthcare Solutions, Inc. | 22 | $315 |
| GENZYME CORPORATION | 7 | $202 |
| Viatris Specialty LLC | 12 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $146 |
| Merck Sharp & Dohme LLC | 8 | $138 |
| Electromed, Inc. | 6 | $123 |
| Amgen Inc. | 5 | $73 |
Products named: DUPIXENT, Arikayce, TRELEGY ELLIPTA, FASENRA, NUCALA, TEZSPIRE, YUPELRI, SMARTVEST.
Industry payments across TX — which companies pay providers there.
